Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HFS6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 22 | 26 | PF00656 | 0.344 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.491 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.438 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.438 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 86 | 88 | PF00082 | 0.435 |
CLV_PCSK_PC7_1 | 10 | 16 | PF00082 | 0.505 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.645 |
DOC_CYCLIN_RxL_1 | 93 | 104 | PF00134 | 0.696 |
DOC_MAPK_gen_1 | 49 | 58 | PF00069 | 0.355 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.699 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.622 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.279 |
LIG_LIR_Gen_1 | 53 | 63 | PF02991 | 0.189 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.384 |
LIG_Pex14_1 | 41 | 45 | PF04695 | 0.433 |
LIG_Pex14_2 | 55 | 59 | PF04695 | 0.366 |
LIG_Pex14_2 | 63 | 67 | PF04695 | 0.300 |
LIG_Pex14_2 | 71 | 75 | PF04695 | 0.235 |
LIG_SH2_CRK | 16 | 20 | PF00017 | 0.654 |
LIG_SH2_NCK_1 | 16 | 20 | PF00017 | 0.654 |
LIG_SH2_STAT3 | 134 | 137 | PF00017 | 0.714 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.636 |
LIG_SH3_3 | 135 | 141 | PF00018 | 0.627 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.275 |
LIG_TYR_ITIM | 107 | 112 | PF00017 | 0.624 |
LIG_WRC_WIRS_1 | 68 | 73 | PF05994 | 0.289 |
LIG_WW_1 | 29 | 32 | PF00397 | 0.203 |
MOD_Cter_Amidation | 84 | 87 | PF01082 | 0.406 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.279 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.629 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.524 |
MOD_PIKK_1 | 50 | 56 | PF00454 | 0.483 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.522 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.629 |
MOD_SUMO_for_1 | 107 | 110 | PF00179 | 0.643 |
MOD_SUMO_rev_2 | 115 | 121 | PF00179 | 0.639 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.682 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.657 |
TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.328 |
TRG_ER_diArg_1 | 14 | 16 | PF00400 | 0.713 |
TRG_ER_diArg_1 | 145 | 147 | PF00400 | 0.682 |
TRG_ER_diArg_1 | 78 | 81 | PF00400 | 0.614 |
TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.706 |
TRG_Pf-PMV_PEXEL_1 | 96 | 101 | PF00026 | 0.498 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5S2 | Leptomonas seymouri | 86% | 100% |
A0A0S4JKA8 | Bodo saltans | 57% | 100% |
A0A1X0P4E7 | Trypanosomatidae | 76% | 100% |
A0A3S7X0S8 | Leishmania donovani | 90% | 100% |
A4I366 | Leishmania infantum | 90% | 100% |
D0A618 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 76% | 100% |
E9ADC9 | Leishmania major | 90% | 100% |
E9AZ54 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |